Palvella Therapeutics, Inc. (PVLA) Analyst Forecast

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$130.5
Day's range
$138.89

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
12/16/2025 Canaccord Genuity Whitney Ijem $204.00 $88.42   130.72%
12/16/2025 Raymond James Ryan Deschner $193.00 $91.51   110.91%
12/15/2025 BTIG Jeff Mukherjee $192.00 $88.42   117.15%
12/15/2025 UBS Catherine Novack $143.00 $88.42   61.73%
12/11/2025 H.C. Wainwright Andrew Fein $190.00 $96.55   96.79%
12/04/2025 Craig-Hallum Albert Lowe $175.00 $91.91   90.4%
11/24/2025 Stifel Nicolaus Samimy Annabel $145.00 $94.09   54.11%
10/02/2025 Truist Financial Danielle Brill $80.00 $61.69   29.68%
09/24/2025 Stifel Nicolaus Annabel Samimy $80.00 $59.87   33.62%
08/15/2025 H.C. Wainwright Andres Maldonado $75.00 $45.94   63.26%
05/16/2025 Canaccord Genuity Whitney Ijem $52.00 $22.05   135.83%
03/25/2025 Stifel Nicolaus Annabel Samimy $45.00 $27.27   65.02%
12/18/2024 Cantor Fitzgerald Josh Schimmer $30.00 $11.79   154.45%

Palvella Therapeutics Inc. FAQ's

Palvella Therapeutics Inc. has been rated by research analysts at Stephens, Truist Financial, Chardan Capital, Stifel Nicolaus, H.C. Wainwright, Mizuho Securities in the past 90 days.